Literature DB >> 26990716

The implementation of a transanal endoscopic microsurgery programme: initial experience with surgical performance.

R M Helewa1, A N Rajaee2, I Raiche2, L Williams2, M Paquin-Gobeil2, R P Boushey2, H Moloo2.   

Abstract

AIM: Despite transanal endoscopic microsurgery (TEM) being used for over 30 years, there has been slow adoption of this modality in many centres. There remains a paucity of research regarding the learning curve and early performance of surgeons who begin to offer TEM. We sought to determine predictors of longer rates of tumour excision and improvements in operative time in a newly established TEM programme.
METHOD: All patients who underwent TEM at the Ottawa Hospital, Ottawa, Canada, between October 2009 and September 2014 were included. Data were abstracted through a retrospective chart review. The average rate of lesion excision (ARE) was calculated to standardize the operation time by size of the pathological specimen (min/cm3 ), representing a measure of surgical efficiency. Surgical efficiency was plotted using restricted cubic splines. Predictors of higher ARE were determined using multivariable regression.
RESULTS: During the study period 108 patients underwent TEM. ARE was available for 95 patients of mean age 67.2 years. The mean ARE was 18.6 min/cm3 . On adjusting for important covariates, the ARE improved with each additional case until 16 cases were completed. Significant predictors of higher ARE on multivariable analysis were age < 50 years, experience of fewer than five cases, and carcinoid/gastrointestinal stromal tumour or scar histology.
CONCLUSION: Operative efficiency appears to improve as surgeons completed 16 TEM cases. We have identified important factors that result in longer operating time. The study has important implications with regard to surgical training and operative planning for new TEM programmes. Colorectal Disease
© 2016 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Transanal endoscopic microsurgery; surgical efficiency; surgical performance

Mesh:

Year:  2016        PMID: 26990716     DOI: 10.1111/codi.13333

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  8 in total

1.  TAMIS is a valuable alternative to TEM for resection of intraluminal rectal tumors.

Authors:  F Van den Eynde; J Jaekers; S Fieuws; A M D'Hoore; A M Wolthuis
Journal:  Tech Coloproctol       Date:  2019-03-11       Impact factor: 3.781

2.  Establishing the learning curve of transanal minimally invasive surgery for local excision of rectal neoplasms.

Authors:  Lawrence Lee; Justin Kelly; George J Nassif; Deborah Keller; Teresa C Debeche-Adams; Paul A Mancuso; John R Monson; Matthew R Albert; Sam B Atallah
Journal:  Surg Endosc       Date:  2017-08-15       Impact factor: 4.584

Review 3.  Transanal Endoscopic Surgery: Who Should Be Doing This Procedure?

Authors:  François Rouleau Fournier; Carl James Brown
Journal:  Clin Colon Rectal Surg       Date:  2022-02-28

Review 4.  Transanal Endoscopic Platforms: TAMIS versus Rigid Platforms: Pros and Cons.

Authors:  Liam A Devane; Meghan C Daly; Matthew R Albert
Journal:  Clin Colon Rectal Surg       Date:  2022-02-28

5.  Transanal endoscopic microsurgery as optimal option in treatment of rare rectal lesions: A single centre experience.

Authors:  Monica Ortenzi; Roberto Ghiselli; Maria Michela Cappelletti Trombettoni; Luca Cardinali; Mario Guerrieri
Journal:  World J Gastrointest Endosc       Date:  2016-09-16

6.  Defining the learning curve for transanal total mesorectal excision for rectal adenocarcinoma.

Authors:  Lawrence Lee; Justin Kelly; George J Nassif; Teresa C deBeche-Adams; Matthew R Albert; John R T Monson
Journal:  Surg Endosc       Date:  2018-07-11       Impact factor: 4.584

Review 7.  Current Challenges for Education and Training in Transanal Surgery.

Authors:  Meagan Costedio
Journal:  Clin Colon Rectal Surg       Date:  2021-03-29

8.  Use of rectal mucosal grafts in substitution urethroplasty: an early series.

Authors:  M Francesca Monn; Joshua A Waters; Matthew J Mellon
Journal:  Transl Androl Urol       Date:  2018-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.